NEUE IMMUNKONJUGATE

European patent · EP2702074 · In force

Register entry

Publication number
EP2702074
Application number
EP12717674
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 26, 2012
Published
Mar 5, 2014
Granted
Nov 21, 2018
Protection ends at the latest
Apr 25, 2032
Next annual fee due
Apr 30, 2026
IPC classes
C07K 16/28 (2006.01)
C07K 16/30 (2006.01)
C07K 16/40 (2006.01)
A61K 39/00 (2006.01)
A61K 38/20 (2006.01)
A61K 47/68 (2017.01)
C07K 14/52 (2006.01)
C07K 14/55 (2006.01)
C07K 14/54 (2006.01)
A61K 39/395 (2006.01)
C07K 16/46 (2006.01)
C07K 16/18 (2006.01)
Priority
EP 11164237 29.04.2011
PCT application
PCT/EP2012/057587 26.04.2012
PCT publication
WO2012/146628 01.11.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  2. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  3. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  4. Oct 19, 2021

    Address changed

    Owner
    Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren

    Published in Swissreg on 19.10.2021

  5. Nov 21, 2018

    Granted

    Published in Swissreg on 21.11.2018

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.